Carlos G Santos-Gallego Selected Research

Carlos G Santos-Gallego Research Topics

Disease

17	Heart Failure 12/2022 - 01/2018
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 06/2007
6	Atherosclerosis 01/2016 - 03/2008
5	Type 2 Diabetes Mellitus (MODY) 10/2022 - 03/2005
4	Fibrosis (Cirrhosis) 01/2021 - 03/2016
4	Coronary Disease (Coronary Heart Disease) 01/2021 - 06/2011
3	Hemorrhage 01/2021 - 06/2010
3	Myocardial Infarction 09/2020 - 01/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022 - 01/2020
2	Acute Coronary Syndrome 01/2021 - 04/2014
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2019
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 06/2010
2	Infarction (Infarctions) 01/2019 - 03/2016
2	Stroke (Strokes) 11/2017 - 06/2010
2	Thrombosis (Thrombus) 04/2014 - 06/2010
1	Cardiomegaly (Heart Hypertrophy) 12/2022
1	Necrosis 10/2022
1	Chronic Renal Insufficiency 10/2022
1	Hypertension (High Blood Pressure) 11/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Diabetes Mellitus 07/2019
1	Transient Ischemic Attack 11/2017
1	Atrial Fibrillation 11/2017
1	Hypertrophy 03/2016
1	Multiple Sclerosis 03/2016
1	Ischemia 03/2016
1	Ventricular Remodeling 03/2016
1	Reperfusion Injury 03/2016
1	Pulmonary Hypertension 07/2015
1	Rupture 04/2014
1	Pathologic Constriction (Stenosis) 06/2010
1	Atherosclerotic Plaque (Atheroma) 03/2008
1	Neoplasms (Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

10	empagliflozinIBA 10/2022 - 01/2018
7	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2022 - 12/2018
7	Sodium-Glucose Transport ProteinsIBA 12/2022 - 12/2018
6	HDL CholesterolIBA 07/2022 - 08/2008
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 04/2019 - 12/2018
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014 - 08/2008
3	AnticoagulantsIBA 01/2020 - 06/2010
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2011 - 03/2008
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2019
2	Dronedarone FDA Link 11/2017 - 06/2010
2	HDL LipoproteinsIBA 12/2014 - 06/2011
2	LipidsIBA 04/2014 - 03/2008
2	LDL CholesterolIBA 06/2011 - 08/2008
1	dapagliflozinIBA 10/2022
1	ConnectinIBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 11/2020
1	SymportersIBA 10/2020
1	SodiumIBA 10/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 04/2019
1	Clostridium perfringens epsilon-toxinIBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2019
1	Branched-Chain Amino AcidsIBA 01/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2016
1	Phosphotransferases (Kinase)IBA 03/2016
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2016
1	CadmiumIBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	Heavy MetalsIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 03/2011
1	Dabigatran FDA Link 06/2010
1	Warfarin (Coumadin)FDA LinkGeneric 06/2010
1	Thrombin FDA Link 06/2010
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2010
1	oxidized low density lipoproteinIBA 08/2008
1	apolipoprotein A-I MilanoIBA 03/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2007
1	ThiazolidinedionesIBA 03/2005
1	Pioglitazone (Actos)FDA Link 03/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2003

Therapy/Procedure

4	Therapeutics 09/2020 - 06/2010
1	Secondary Prevention 01/2021
1	Denervation 07/2015
1	Catheters 07/2015
1	Intravenous Administration 03/2011
1	Thrombolytic Therapy 06/2010
1	Carotid Endarterectomy 06/2010
1	Chemoprevention 02/2003
1	Immunomodulation 02/2003